Novel Approaches to Gynecologic Cancers Biology and Treatment
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (31 May 2024) | Viewed by 700
Special Issue Editors
Interests: gynecology; gynecologic oncology; uterine sarcoma; endometrial cancer; cancer immunology; chemosensitivity; tumor microenvironment; target therapy; angiogenesis; lymphangiogenesis
Special Issue Information
Dear Colleagues,
In recent years, rapid developments in both basic and clinical research have been observed in the field of gynecologic oncology. Multiple therapeutic methods have been introduced and developed, deeply altering the landscape of female genital cancer treatment.
Nowadays, we can offer our patients a variety of targeted treatments, from immunotherapy, PARP inhibitors, anti- angiogenic drugs, to microinvasive surgeries. Multiple novel drugs and methods are currently under investigation and are expected to be included as a standard of care in the coming years. However, clinicians have to be aware that any progress in medicine is not possible without the development of basic sciences.
The aim of this Special Issue of Cancers is to provide a platform for researchers and practitioners to present their high-quality original and review papers covering the results of basic research, as well as clinical investigations dedicated to extending our knowledge of ovarian, endometrial, cervical and vulvar cancer.
The scope of this Special Issue includes reports of both surgical and medical interventions aiming to improve the diagnostics and treatment of gynecologic cancer. Articles based on experimental results will provide novel insights into the biology of gynecologic malignancies, and reports of well-designed experiments employing novel drugs will be welcome.
This Special issue will highlight new, multidisciplinary approaches to research in the field, and will indicate further directions for future development.
Dr. Marcin Bobiński
Dr. Monika Abramiuk
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- ovarian cancer
- endometrial cancer
- cervical cancer
- targeted therapy
- tumor immunity
- tumor microenvironment
- gynecological surgery
- gynecologic oncology
